Rita Kočárová

Rita Kočárová, MSc.

Rita Kočárová, MSc.

Psychedelic Harm-Prevention

Use of psychedelics is associated with wide range of consequences, not always beneficial for the individuals, societies, and our environment.

What challenges we face nowadays in terms of risks of use of psychedelics? How we deal with them? What can be done more to reduce and prevent harms caused by their use?

This space will serve as a platform for an open discussion about risks and their reduction, or better to say their prevention. We will attempt to identify the main risks of use of psychedelics, review the current services and activities established to reduce potential harms and facilitate gaining benefits, identify the gaps in the current system, and create a list of standards for safe and responsible use.

This workshop is open to the researchers, practitioners, but also to psychonauts and other interested people.

RITA KOČÁROVÁ, MSc, is a junior researcher at National Institute of Mental Health (NIMH) in the research program of Social Psychiatry and in the on-going psilocybin study, PhD student of clinical psychology at Charles University in Prague, trainee of Gestalt therapy and MDMA for PTSD therapy (MAPS), and executive director of Beyond Psychedelics - multidisciplinary global forum on psychedelics.  She is also a co-founder of Czech Psychedelic Society. In her research she focuses on mechanism of therapeutic functioning of psychedelics on psychological level, especially psilocybin, ayahuasca, and recently also natural substances containing 5-MeO-DMT and bufotenin (Bufo alvarius toad, yopo), therapeutic use of psychedelic drugs, studies with psychedelics and deliriants conducted in 60s in former Czechoslovakia and also complex approach to the addictions. Besides research, she is providing psychological support with the integration of the psychedelic sessions. She was at the research internship in Takiwasi Center in Peru in 2014. She is a member of scientific committee of International Transpersonal Conference 2017, Young Psychiatrists Network Meeting and Rational Drug Regulation.